See What HealthDay Can Do For You
Contact Us

Health Highlights: July 7 2020

Two Lysol Products Can Kill Coronavirus: EPA Brazil's President Diagnosed With COVID-19 Efforts to Reduce HIV infections in Children Faltering: Report Company Gets $1.6 Billion From U.S. Government for Coronavirus Vaccine Coronavirus Antibody Cocktail Begins Late-Stage Human Trials Suspected Plague Case Reported in China Miami-Dade County Orders Re-Closure of Some Indoor Spaces

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Two Lysol Products Can Kill Coronavirus: EPA

Two Lysol products are the first to be approved by the U.S. Environmental Protection Agency as able to kill the new coronavirus on hard, non-porous surfaces.

The EPA said laboratory tests found that Lysol Disinfectant Spray and Lysol Disinfectant Max Cover Mist destroy the virus two minutes after contact, CNN reported.

The agency says there are 420 disinfectant products that are effective against "harder-to-kill" viruses than the new coronavirus, but the two Lysol are products are the first to be tested directly against the virus and able to kill it.

A recent U.S. Centers for Disease Control and Prevention survey found that Americans said they were cleaning more often because of the coronavirus pandemic, but only about half said they actually knew how to clean and disinfect their home safely, CNN reported.


Brazil's President Diagnosed With COVID-19

After months of downplaying the new coronavirus, Brazilian President Jair Bolsonaro has tested positive for COVID-19.

He was tested on Monday and announced the result on TV Tuesday, CNN reported.

"Everyone knew that it would reach a considerable part of the population sooner or later. It was positive for me," he said.

On Monday, CNN Brasil reported that Bolsonaro had symptoms consistent with COVID-19, including a fever, but Bolsonaro's office told the news outlet on Tuesday that his temperature was normal.


Efforts to Reduce New HIV infections in Children Faltering: Report

Efforts to reduce new HIV infections in children worldwide are faltering, according to a new report on progress towards Start Free, Say Free, AIDS Free targets.

Countries agreed to a range of HIV prevention and treatment goals, including reducing new child (ages 014 years) HIV infections to less than 40,000 by 2018 and 20,000 by 2020.

But new estimates show that 150,000 children were newly infected with HIV in 2019, a 52% reduction since 2010, but still four times more than the 2018 target, according to the UNAIDS report.

"To see so many tools available, so many new HIV infections among children that have been prevented, so many children living with HIV doing well, but to see others missed and still left behind is a tragedy," Winnie Byanyima, executive director of UNAIDS, said in a news release from the organization.

"We cannot accept that tens of thousands of children still become infected with HIV and die from AIDS-related illnesses every year," Byanyima added.

When a pregnant women with HIV is diagnosed, starts on and keeps taking antiretroviral medicines during pregnancy, delivery and breastfeeding, the risk that she'll pass HIV to her baby is less than 1%.

In 2019, 85% of pregnant women with HIV received those medicines. Despite this high rate, children are still becoming infected due to unequal access to treatment services (primarily in western and central Africa), women falling out of care, and pregnant and breastfeeding women becoming newly infected with HIV, according to the report.

"As a global community, we have made remarkable progress toward controlling the HIV pandemic, yet we are still missing far too many children, adolescents and young women," Angeli Achrekar, principal deputy United States Global AIDS coordinator, United States President's Emergency Plan for AIDS Relief, said in the news release.

"We must all redouble our efforts to urgently reach these critical population, and PEPFAR remains deeply committed to doing its part," Achrekar said.


Company Gets $1.6 Billion From U.S. Government for Coronavirus Vaccine

Vaccine maker Novavax will receive $1.6 billion from the U.S. government to provide 100 million doses of a coronavirus vaccine by early 2021, the Maryland-based company said Monday.

This is the largest deal announced by the Trump administration to date as part of its attempts to provide coronavirus vaccines and treatments to Americans as soon as possible, The New York Times reported.

The $1.6 billion is coming from a "collaboration" between the Health and Human Services Department and the Defense Department, according to a Novavax spokeswoman.

In May, the Trump administration said it would give up to $1.2 billion to British drugmaker AstraZeneca, which has said it could have a vaccine available by October. Federal funding has also been given to four other companies -- Moderna Therapeutics, Johnson & Johnson, Merck and Sanofi -- for their experimental coronavirus vaccines, The Times reported.

Novavax has never brought a product to market, the Times reported.


Coronavirus Antibody Cocktail Begins Late-Stage Human Trials

Late-stage human trials to assess whether a double antibody cocktail can prevent and treat coronavirus infection have started, biotechnology company Regeneron said Monday.

A Phase 3 trial of REGN-COV2 will assess whether it can prevent coronavirus infection among uninfected people who've had close contact with an infected person, CNN reported.

The trial is being conducted at about 100 sites across the United States and is expected to included 2,000 people.

Phase 2/3 trials are underway to determine if the antibody cocktail can treat hospitalized and non-hospitalized COVID-19 patients, according to Regeneron. The trials, which will include 1,850 hospitalized patients and 1,050 non-hospitalized patients, are planned for 150 sites in the United States, Brazil, Mexico and Chile, CNN reported.

These aren't the only human trials of COVID-19 antibody drugs. Eli Lilly and AbCellera started testing their antibody therapies in humans on June 1, and a number of other companies are working on antibody treatments, CNN reported.


Suspected Plague Case Reported in China

A suspected bubonic plague case in the Bayannur district of the Inner Mongolia Autonomous Region of China has been reported by local officials.

Residents were told not to hunt wild animals such as marmots and that anyone with fever or other possible signs of infection should seek treatment, CBS News reported.

Plague can be treated with antibiotics. If not treated, plague can be fatal in up to 90% of cases.

While largely eradicated in China, there are still occasional cases in the country. The last major known outbreak was in 2009 in the town of Ziketan in Qinghai province on the Tibetan Plateau, CBS News reported.


Miami-Dade County Orders Re-Closure of Some Indoor Spaces

Restaurants, gyms and certain other indoor spaces in Miami-Dade County were ordered to close again Monday after there was a spike in confirmed coronavirus cases and hospitalizations in Florida's most most populous county.

The emergency order was issued by Mayor Carlos Gimenez seven weeks after those locations were allowed to reopen, the Associated Press reported.

"We want to ensure that our hospitals continue to have the staffing necessary to save lives," Gimenez said in a statement.

Hair salons, stores, hotel pools and summer camps in the county will remain open, and beaches will reopen on Tuesday after being closed over the weekend, the AP reported.

"But if we see crowding and people not following the public health rules, I will be forced to close the beaches again," Giminez said.

Florida recorded an all-time high of 11,400 coronavirus cases Saturday and its positive test rate over the past two weeks has increased to more than 18%, according to the AP.

Confirmed cases are climbing in 41 out of 50 states and the District of Columbia, and the percentage of tests coming back positive for the virus is on the rise in 39 states.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.